Clinical Trial Update: A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Type 2 DM After Failure of an Oral Triple Anti-diabetic Regimen [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating teneligliptin added to quadruple oral therapy after failure of triple therapy in type 2 diabetes mellitus; results completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Teneligliptin (Teneligliptin)

Snippet

Sponsor: Yonsei University | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED